Prognostic impact of prevalent chronic lymphocytic leukemia stereotyped subsets: analysis within prospective clinical trials of the German CLL Study Group (GCLLSG) | Haematologica
![The combination of complex karyotype subtypes and IGHV mutational status identifies new prognostic and predictive groups in chronic lymphocytic leukaemia | British Journal of Cancer The combination of complex karyotype subtypes and IGHV mutational status identifies new prognostic and predictive groups in chronic lymphocytic leukaemia | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41416-019-0502-x/MediaObjects/41416_2019_502_Fig1_HTML.png)
The combination of complex karyotype subtypes and IGHV mutational status identifies new prognostic and predictive groups in chronic lymphocytic leukaemia | British Journal of Cancer
![Prognostic Testing Patterns and Outcomes of Chronic Lymphocytic Leukemia Patients Stratified by Fluorescence In Situ Hybridization/Cytogenetics: A Real-world Clinical Experience in the Connect CLL Registry - ScienceDirect Prognostic Testing Patterns and Outcomes of Chronic Lymphocytic Leukemia Patients Stratified by Fluorescence In Situ Hybridization/Cytogenetics: A Real-world Clinical Experience in the Connect CLL Registry - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2152265017315392-gr1.jpg)
Prognostic Testing Patterns and Outcomes of Chronic Lymphocytic Leukemia Patients Stratified by Fluorescence In Situ Hybridization/Cytogenetics: A Real-world Clinical Experience in the Connect CLL Registry - ScienceDirect
![Frontiers | Identification of Clinically Relevant Subgroups of Chronic Lymphocytic Leukemia Through Discovery of Abnormal Molecular Pathways Frontiers | Identification of Clinically Relevant Subgroups of Chronic Lymphocytic Leukemia Through Discovery of Abnormal Molecular Pathways](https://www.frontiersin.org/files/Articles/627964/fgene-12-627964-HTML/image_m/fgene-12-627964-g001.jpg)
Frontiers | Identification of Clinically Relevant Subgroups of Chronic Lymphocytic Leukemia Through Discovery of Abnormal Molecular Pathways
Impact of cytogenetic and molecular prognostic markers on the clinical management of chronic lymphocytic leukemia | Haematologica
Impact of cytogenetic and molecular prognostic markers on the clinical management of chronic lymphocytic leukemia | Haematologica
![Diagnostics | Free Full-Text | The Evolving Landscape of Chronic Lymphocytic Leukemia on Diagnosis, Prognosis and Treatment Diagnostics | Free Full-Text | The Evolving Landscape of Chronic Lymphocytic Leukemia on Diagnosis, Prognosis and Treatment](https://www.mdpi.com/diagnostics/diagnostics-11-00853/article_deploy/html/images/diagnostics-11-00853-g001.png)
Diagnostics | Free Full-Text | The Evolving Landscape of Chronic Lymphocytic Leukemia on Diagnosis, Prognosis and Treatment
![Genetic Testing Can Help to Guide the Treatment of Patients with Chronic Lymphocytic Leukemia - CONQUER: the patient voice Genetic Testing Can Help to Guide the Treatment of Patients with Chronic Lymphocytic Leukemia - CONQUER: the patient voice](https://conquer-magazine.com/images/issues/2018/October/table.png)
Genetic Testing Can Help to Guide the Treatment of Patients with Chronic Lymphocytic Leukemia - CONQUER: the patient voice
![Frontiers | Importance of Crosstalk Between Chronic Lymphocytic Leukemia Cells and the Stromal Microenvironment: Direct Contact, Soluble Factors, and Extracellular Vesicles Frontiers | Importance of Crosstalk Between Chronic Lymphocytic Leukemia Cells and the Stromal Microenvironment: Direct Contact, Soluble Factors, and Extracellular Vesicles](https://www.frontiersin.org/files/Articles/552260/fonc-10-01422-HTML/image_m/fonc-10-01422-g001.jpg)
Frontiers | Importance of Crosstalk Between Chronic Lymphocytic Leukemia Cells and the Stromal Microenvironment: Direct Contact, Soluble Factors, and Extracellular Vesicles
![Chronic Lymphocytic Leukemia: Prognostic Factors and Impact on Treatment - Terri L Parker - Discovery Medicine Chronic Lymphocytic Leukemia: Prognostic Factors and Impact on Treatment - Terri L Parker - Discovery Medicine](https://www.discoverymedicine.com/Terri-L-Parker/files/2011/02/discovery_medicine_matthew_p_strout_no_57_table_3.png)